Insider Selling: Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider Sells 138,705 Shares of Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider Fred Burke sold 138,705 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $2,796,292.80. Following the transaction, the insider now owns 413,019 shares of the company's stock, valued at $8,326,463.04. This trade represents a 25.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Fred Burke also recently made the following trade(s):

• On Tuesday, May 27th, Fred Burke sold 747,102 shares of Guardian Pharmacy Services stock. The shares were sold at an average price of $20.16, for a total value of $15,061,576.32.

Guardian Pharmacy Services Stock Up 2.3%

Guardian Pharmacy Services stock traded up $0.49 during mid-day trading on Tuesday, reaching $21.78. 290,686 shares of the company were exchanged, compared to its average volume of 169,453. The business has a fifty day moving average of $23.19 and a 200 day moving average of $22.01. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to the consensus estimate of $321.21 million. On average, analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Large investors have recently made changes to their positions in the business. R Squared Ltd acquired a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $30,000. BNP Paribas Financial Markets acquired a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $37,000. Compass Financial Services Inc acquired a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $58,000. JPMorgan Chase & Co. acquired a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $77,000. Finally, Quantbot Technologies LP acquired a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $81,000.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on GRDN shares. Wall Street Zen lowered Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Raymond James set a $28.00 price target on Guardian Pharmacy Services and gave the company an "outperform" rating in a report on Wednesday, May 14th. Finally, Truist Financial restated a "buy" rating and set a $28.00 target price (up previously from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.